Study of a new pump treatment for advanced Parkinson's
Part of Brain & nervous system clinical trials.
This study looks at a new pump treatment (foslevodopa/foscarbidopa) for people with advanced Parkinson's who are having motor fluctuations. It aims to see if it improves quality of life when started earlier in the advanced stage.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 80 years old
- You have had Parkinson's for less than 10 years
- You experience motor fluctuations (wearing off) for 3 years or less
- You have 2.5 to 6 hours of "off" time each day
- You have never used a device therapy like deep brain stimulation or an apomorphine pump
- You are able to fill out questionnaires on an electronic tablet
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a new pump-delivered combination of Parkinson's medications (foslevodopa/foscarbidopa) in adults who have recently started having motor fluctuations but are not yet using other device therapies. It aims to see how well it works in real life and may offer better symptom control.
This study looks at how well a treatment called foslevodopa/foscarbidopa works for people with advanced Parkinson's disease. It is given as a shot under the skin (subcutaneous) and is already being used in clinics. The study will follow people who are already starting this treatment as part of their regular care.
This study observes how well a new type of levodopa/carbidopa treatment works in real-world practice for people with advanced Parkinson's disease who are already using it. It aims to understand patient experiences and the support program offered by the drug maker.
This study tests an investigational drug to see if it can help people with early Parkinson's disease. It may offer a new treatment option to manage symptoms.
This study tests an experimental treatment (LY3962681) for people with early Parkinson's. It aims to see if the treatment is safe and can slow the disease. You must have a confirmed diagnosis, be in good overall health, and have stable medication use.
This study follows people with Parkinson’s who have troublesome “ups and downs” or involuntary movements, and who need a device/infusion treatment like deep brain stimulation, an apomorphine pump, or a Duodopa pump. It helps doctors see how these second-line treatments are working in real life and what outcomes they produce.
Hear when a new Parkinson’s disease trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.